Evidence map›Paper›PMID 38428403›Full record

ArticleAging2024

Ningxin-Tongyu-Zishen formula alleviates the senescence of granulosa cells on D-galactose-induced premature ovarian insufficiency mice.

Jia-Wen Ma, Zeng-Yan Xiong, Xing-Chu Cai, Xiang Li, Shi-Yan Ren, Shuai-Qi An, Zai-Yang Zhang, Yi-Zhou Zhang

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Aging, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 3 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Jia-Wen MaSchool of Basic Medical Sciences, Zhejiang Chinese Medical University, Hangzhou, China.
Zeng-Yan XiongSchool of Basic Medical Sciences, Zhejiang Chinese Medical University, Hangzhou, China.
Xing-Chu CaiSchool of Basic Medical Sciences, Zhejiang Chinese Medical University, Hangzhou, China.
Xiang LiSchool of Basic Medical Sciences, Zhejiang Chinese Medical University, Hangzhou, China.
Shi-Yan RenSchool of Basic Medical Sciences, Zhejiang Chinese Medical University, Hangzhou, China.
Shuai-Qi AnSchool of Basic Medical Sciences, Zhejiang Chinese Medical University, Hangzhou, China.
Zai-Yang ZhangSchool of Basic Medical Sciences, Zhejiang Chinese Medical University, Hangzhou, China.
Yi-Zhou ZhangSchool of Basic Medical Sciences, Zhejiang Chinese Medical University, Hangzhou, China.
Zhejiang Chinese Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ningxin-Tongyu-Zishen formula (NTZF) is a clinical experience formula for the treatment of premature ovarian insufficiency (POI) in traditional Chinese medicine (TCM), and the potential mechanism is unknown. For

Indexed as

GalactosePrimary Ovarian InsufficiencyAnimalsCellular SenescenceFemaleGranulosa CellsHumansHydrogen PeroxideMiceMice, Inbred C57BLRNA, MessengerSirtuin 1Tumor Suppressor Protein p53GalactoseHydrogen PeroxideRNA, MessengerSirtuin 1Tumor Suppressor Protein p53cell senescenceNingxin-Tongyu-Zishen formulaovarian granulosa cellspremature ovarian insufficiencySirt1/p53

Identifiers

PMID38428403
PMCPMC10968698
OpenAlexW4392241875

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.